Precigen
PGEN
138 hedge funds and large institutions have $86M invested in Precigen in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 41 increasing their positions, 38 reducing their positions, and 12 closing their positions.
681% more call options, than puts
Call options by funds: $164K | Put options by funds: $21K
30% more capital invested
Capital invested by funds: $66M → $86M (+$20M)
1.25% more ownership
Funds ownership: 22.46% → 23.72% (+1.3%)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
8% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 38
0% more funds holding
Funds holding: 138 → 138 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Patient Capital Management
Baltimore,
Maryland
|
+$3.56M |
| 2 |
Millennium Management
New York
|
+$1.87M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.32M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$474K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$385K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$1.78M |
| 2 |
SEI Investments
Oaks,
Pennsylvania
|
-$1.2M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$945K |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
-$245K |
| 5 |
Renaissance Technologies
New York
|
-$236K |
PGEN Hedge Fund Activity: Q3 2023 in Review
138 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q3 2023, worth a combined $86M — up 30% from $66M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new PGEN positions and 12 closed out — a net gain of 1 holder — while 41 added to existing stakes and 38 trimmed.
The largest buyer was Patient Capital Management, adding an estimated $3.56M. The largest seller was Iridian Asset Management, cutting an estimated $1.78M.
- 138 institutional investors held Precigen (PGEN) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $86M of Precigen stock for Q3 2023, up 30% quarter-over-quarter.
- 13 funds opened new Precigen positions in Q3 2023 and 12 closed out, a net change of +1 holder.
- The largest Precigen buyer in Q3 2023 was Patient Capital Management, an estimated $3.56M added.
- The largest Precigen seller in Q3 2023 was Iridian Asset Management, an estimated $1.78M sold.
Based on aggregated 13F filings for Q3 2023.